CTNNBIP1 and lung cancer: A low expression of CTNNBIP1 is correlated with a high level of expression of MMP7, and there is also an upward trend in terms of the pathological stage and poorer patient survival, which suggests that CTNNBIP1 may be able to serve as a prognostic biomarker for lung cancer.